Cascades Reports Results for the Fourth Quarter and Full Year 2021

Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period and fiscal year ended December 31, 2021.

Q4 2021 Highlights (comparative figures have been restated to reflect discontinued operations2)
Sales of $1,028 million (compared with $1,030 million in Q3 2021 and $1,030 million in Q4 2020)
As reported (including specific items)
Operating income (loss) of $(90) million (compared with $73 million in Q3 2021 and $104 million in Q4 2020)
Operating income (loss) before depreciation and amortization (OIBD) of $(30) million (compared with $136 million in Q3 2021 and $163 million in Q4 2020)
Net earnings per common share of $1.04 (compared with $0.32 in Q3 2021 and $0.72 in Q4 2020)
Adjusted (excluding specific items1)
Operating income of $2 million (compared with $44 million in Q3 2021 and $80 million in Q4 2020)
OIBD of $62 million (compared with $107 million in Q3 2021 and $139 million in Q4 2020)
Net loss per common share of $(0.09) (compared with net loss per common share of $(0.01) in Q3 2021 and net earnings per common share of $0.42 in Q4 2020)

2021 Annual Highlights (comparative figures have been restated to reflect discontinued operations2)
Sales of $3,956 million (compared with $4,105 million in 2020)
As reported (including specific items)
Operating income of $50 million (compared with $292 million in 2020)
Operating income before depreciation and amortization (OIBD) of $302 million (compared with $543 million in 2020)
Net earnings per common share of $1.60 (compared with $2.04 in 2020)
Adjusted (excluding specific items1)
Operating income of $137 million (compared with $295 million in 2020)
OIBD of $389 million (compared with $546 million in 2020)
Net earnings per common share of $0.26 (compared with $1.95 in 2020)
Financial information for the Boxboard Europe segment is presented as discontinued operations following the monetization of the Corporation’s 57.6% controlling equity interest in Reno de Medici S.p.A. (RDM) which generated net proceeds of $450 million. The transaction was announced in July 2021 and closed on October 26, 20212. The net gain after income tax amounts to $204 million.
Net debt1 of $1,351 million as at December 31, 2021 (compared with $1,760 million as at September 30, 2021). Net debt to adjusted OIBD ratio1 of 3.5x down from 3.8x as at September 30, 2021.
Total capital expenditures, net of disposals, of $233 million in 20212, compared to $164 million in 20202. Forecasted 2022 net capital expenditures of $415 million, encompassing $275 million for the Bear Island containerboard conversion project in Virginia, USA.

Mario Plourde, President and CEO, commented: ” It was a difficult end to the year, and our disappointing fourth quarter results are a consequence of the escalation in costs and operational disruptions that continued to develop as the quarter progressed. Ongoing challenges from supply chain constraints, reduced labour availability and higher logistics costs related to the pandemic were further exacerbated by rail disruptions caused by flooding in Western Canada in November that significantly impeded logistics across Canada, and the subsequent emergence and rapid escalation of the Omicron variant in December. These factors intensified pressures on costs, impacted production levels in several of our operations, and delayed delivery times of products to customers. Notwithstanding this challenging environment the Specialty Products segment continued to perform well, driven by product innovation and strategic commercial decisions.

In the context of this challenging business environment, we continued to take concrete steps to unlock value. The sale of our 57.6% controlling equity position in Reno de Medici S.p.A. generated net proceeds of $450 million, which were used in part to redeem Senior unsecured notes. In addition to this, we continued to return capital to shareholders through the 50% dividend increase in the second quarter, and ongoing share buy-back program that resulted in 1.65 million shares being repurchased in the third quarter.”
details at: https://www.newswire.ca/news-releases/cascades-reports-results-for-the-fourth-quarter-and-full-year-2021-817382847.html

Related Posts

How Novolex Is Building A Brain Trust To Educate Consumers And Achieve Our Sustainability Goals

Novolex employees thrive when developing innovative new products, identifying more sustainable solutions, and stretching the boundaries of packaging to meet unique customer needs. At Novolex, we pride ourselves on collaborating across the industry, cultivating a broader brain trust with others in the manufacturing and packaging space. Certain issues—like recyclability or reusability—we can’t tackle alone. By joining coalitions focused on consumer education, collaborating with foodservice operators, participating in labeling systems like How2Recycle®, and fostering the construction of recycling infrastructure, we support consumers and elevate the entire industry. Last month, the Plastics Industry Association (PLASTICS) launched the Flexible Film Recycling Alliance (FFRA), an initiative Novolex is proud to participate in. The alliance has plans to educate the public about the sustainability and recyclability of flexible plastic film products.

Aptar Receives APR Critical Guidance Recognition for SimpliCycle™ Recyclable Valve

Aptar Food + Beverage, a global leader in elastomeric flow solutions for more than 25 years, has received Critical Guidance Recognition from The Association of Plastic Recyclers (APR) for its SimpliCycle™ recyclable valve technology. APR Critical Guidance Recognition acknowledges technologies or packaging components that solve long-standing problems in sustainable package design. The recognition applies to both specific package design components and packages incorporating the component. SimpliCycle™ passed the required APR Critical Guidance test protocol performed by an independent, third-party testing laboratory.

Sonoco ThermoSafe and ACL Airshop Announce Agreement for Handling and Repair of Pegasus ULD Temperature Controlled Bulk Shippers

Sonoco ThermoSafe and ACL Airshop announced a global agreement for the handling and repair of Sonoco ThermoSafe’s Pegasus ULD bulk temperature controlled containers. The Pegasus ULD™ is the world’s first passive bulk temperature controlled container for pharmaceutical use that is an approved unit load device, which allows it to speed through existing international ground handling and customs processes at the lowest possible cost. Engineered with composite materials, the unit load device will offer a lighter solution that is substantially more damage-resistant than traditional metal containers. Additionally, the Pegasus contains a fully integrated, FAA (Federal Aviation Administration) approved telemetry system, providing real-time, cloud-based data on payload and ambient temperature and key environmental factors, precisely synchronized with GPS location. ACL Airshop, headquartered in Greenville, S.C., and with air cargo support capabilities at more than 50 of the world’s top 100 cargo airports, will initially provide pre-conditioning, handling and repair services at air cargo facilities around the world representing key pharma hubs for import and export. As demand for the Pegasus ULD fleet continues to grow, ACL’s global footprint offers Sonoco ThermoSafe the opportunity to rapidly expand.
Back To Top
×Close search
Search